Repare Therapeutics Inc. (RPTX) NASDAQ
$3.15 0.13 (4.30%)
Market Cap: $116.55M
As of 04/19/24 04:30 PM EDT. Market closed.
Repare Therapeutics Inc. (RPTX)
NASDAQ
$3.15
0.13 (4.30%)
Market Cap: $116.55M
As of 04/19/24 04:30 PM EDT. Market closed.
Add to Portfolio
repare therapeutics is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. its approach integrates insights from several fields of cell biology including dna repair and synthetic lethality. repare’s platform combines a proprietary, high throughput, crispr?enabled gene editing target discovery method with high?resolution protein ... read more
repare therapeutics is developing new, precision oncology drugs for patients that target specific vulnerabilities of tumor cells. its approach integrates insights from several fields of cell biology including dna repair and synthetic lethality. repare’s platform combines a proprietary, high throughput, crispr?enabled gene editing target discovery method with high?resolution protein crystallography, computational biology and clinical informatics. the company is backed by leading global healthcare investors including founding investor versant ventures and mpm capital. for additional information, please visit www.reparerx.com. read less
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
173
URL
Address
.
PRICE CHART FOR REPARE THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$3.02
Previous Close
$3.02
Days Range
$2.99 - $3.27
52 week range
$2.98 - $13.85
Volume
219,182
Avg. Volume (30 days)
121,391
Market Cap
$116.55M
Dividend Yield
-
P/E
(1.24)
Shares Outstanding
37,000,700
Open
$3.02
Previous Close
$3.02
Days Range
$2.99 - $3.27
52 week range
$2.98 - $13.85
Volume
219,182
Avg. Volume (30 days)
121,391
Market Cap
$116.55M
Dividend Yield
-
P/E
(1.24)
Shares Outstanding
37,000,700
FINANCIAL STATEMENTS FOR REPARE THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR REPARE THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | Apr 01, 2024 | Sale | $4.63 | 2,491 | 11,533 | 107,558 | Apr 01, 2024, 09:31 PM |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | Mar 28, 2024 | Sale | $4.62 | 2,650 | 12,243 | 110,049 | Apr 01, 2024, 09:31 PM |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Mar 28, 2024 | Sale | $4.62 | 825 | 3,811 | 45,564 | Apr 01, 2024, 09:30 PM |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Apr 01, 2024 | Sale | $4.61 | 789 | 3,637 | 44,775 | Apr 01, 2024, 09:30 PM |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Apr 01, 2024 | Sale | $4.66 | 410 | 1,911 | 71,908 | Apr 01, 2024, 09:28 PM |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Mar 28, 2024 | Sale | $4.64 | 450 | 2,088 | 72,318 | Apr 01, 2024, 09:28 PM |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Apr 01, 2024 | Sale | $4.66 | 300 | 1,398 | 231,409 | Apr 01, 2024, 09:27 PM |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Mar 28, 2024 | Sale | $4.64 | 500 | 2,320 | 231,709 | Apr 01, 2024, 09:27 PM |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Mar 27, 2024 | Sale | $4.62 | 825 | 3,811 | 42,212 | Mar 27, 2024, 06:59 PM |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Mar 26, 2024 | Sale | $4.60 | 825 | 3,795 | 43,037 | Mar 27, 2024, 06:59 PM |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Mar 25, 2024 | Sale | $4.79 | 825 | 3,952 | 43,862 | Mar 27, 2024, 06:59 PM |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Mar 26, 2024 | Sale | $4.61 | 450 | 2,075 | 73,218 | Mar 27, 2024, 06:57 PM |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Mar 25, 2024 | Sale | $4.78 | 450 | 2,151 | 73,668 | Mar 27, 2024, 06:57 PM |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Mar 27, 2024 | Sale | $4.62 | 450 | 2,079 | 72,768 | Mar 27, 2024, 06:57 PM |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Mar 26, 2024 | Sale | $4.60 | 500 | 2,300 | 232,709 | Mar 27, 2024, 06:56 PM |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Mar 25, 2024 | Sale | $4.78 | 500 | 2,390 | 233,209 | Mar 27, 2024, 06:56 PM |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Mar 27, 2024 | Sale | $4.62 | 500 | 2,310 | 232,209 | Mar 27, 2024, 06:56 PM |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | Mar 27, 2024 | Sale | $4.63 | 2,650 | 12,270 | 83,866 | Mar 27, 2024, 06:54 PM |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | Mar 26, 2024 | Sale | $4.64 | 2,650 | 12,296 | 86,516 | Mar 27, 2024, 06:54 PM |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | Mar 25, 2024 | Sale | $4.79 | 2,650 | 12,693 | 89,166 | Mar 27, 2024, 06:54 PM |
| Koehler Maria | EVP, Chief Medical Officer | Dec 11, 2023 | Option Exercise | $2.26 | 43,746 | 98,755 | 219,709 | Dec 12, 2023, 04:19 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 16, 2023 | Buy | $5.38 | 295,745 | 1,592,202 | 5,309,432 | Nov 17, 2023, 04:54 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 15, 2023 | Buy | $5.00 | 931,556 | 4,657,687 | 5,155,739 | Nov 17, 2023, 04:54 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 02, 2023 | Buy | $3.60 | 783,709 | 2,821,352 | 4,662,402 | Nov 03, 2023, 05:37 PM |
| Zinda Michael | EVP, Chief Scientific Officer | Jun 08, 2023 | Sale | $12.02 | 2,869 | 34,485 | 60,118 | Jun 09, 2023, 04:25 PM |
| Zinda Michael | EVP, Chief Scientific Officer | Jun 07, 2023 | Sale | $12.03 | 6,404 | 77,040 | 62,987 | Jun 09, 2023, 04:25 PM |
| Zinda Michael | EVP, Chief Scientific Officer | Jun 06, 2023 | Sale | $12.04 | 1,200 | 14,448 | 69,391 | Jun 07, 2023, 04:55 PM |
| Koehler Maria | EVP, Chief Medical Officer | Dec 20, 2022 | Option Exercise | $2.06 | 48,507 | 100,040 | 149,513 | Dec 20, 2022, 08:05 PM |
| Jerel Davis | Director | Dec 09, 2022 | Sale | $16.00 | 250,000 | 4,000,000 | 2,094,451 | Dec 13, 2022, 04:18 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jun 13, 2022 | Buy | $12.73 | 149,161 | 1,898,819 | 4,443,423 | Jun 15, 2022, 06:15 PM |
| Versant Vantage I, L.P. | 10% Owner | Jun 03, 2022 | Sale | $12.25 | 750,000 | 9,188,775 | 2,344,451 | Jun 07, 2022, 04:37 PM |
| Versant Ventures V, LLC | 10% Owner | Jun 03, 2022 | Sale | $12.25 | 750,000 | 9,188,775 | 2,344,451 | Jun 07, 2022, 04:36 PM |
| Jerel Davis | Director | Jun 03, 2022 | Sale | $12.25 | 750,000 | 9,188,775 | 2,344,451 | Jun 07, 2022, 04:32 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jun 02, 2022 | Buy | $11.68 | 1,186,045 | 13,855,852 | 4,011,604 | Jun 06, 2022, 06:14 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jun 06, 2022 | Buy | $13.21 | 6,869 | 90,752 | 4,368,757 | Jun 06, 2022, 06:14 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jun 03, 2022 | Buy | $12.29 | 644,044 | 7,912,725 | 4,364,948 | Jun 06, 2022, 06:14 PM |
| BVF PARTNERS L P/IL | 10% Owner | May 18, 2022 | Buy | $8.50 | 420,000 | 3,570,000 | 3,350,950 | May 20, 2022, 06:09 PM |
| Zinda Michael | EVP, Chief Science Officer | Mar 15, 2022 | Sale | $11.30 | 533 | 6,023 | 46,041 | Mar 16, 2022, 04:04 PM |
| BVF PARTNERS L P/IL | 10% Owner | Jan 19, 2022 | Buy | $14.10 | 997,961 | 14,071,250 | 3,126,562 | Jan 21, 2022, 05:12 PM |
| Koehler Maria | EVP, Chief Medical Officer | Dec 10, 2021 | Option Exercise | $2.06 | 48,511 | 100,048 | 101,006 | Dec 10, 2021, 04:43 PM |
| Zinda Michael | EVP, Chief Science Officer | Nov 23, 2021 | Option Exercise | $2.00 | 46,041 | 91,948 | 46,574 | Dec 06, 2021, 04:47 PM |
| Civik Thomas | Director | Nov 16, 2021 | Buy | $28.08 | 7,500 | 210,600 | 7,500 | Nov 18, 2021, 05:00 PM |
| Zinda Michael | EVP, Chief Science Officer | Nov 15, 2021 | Sale | $27.33 | 20,000 | 546,613 | 4,433 | Nov 17, 2021, 07:46 PM |
| Bonita David P | Director | Sep 07, 2021 | Sale | $33.93 | 887 | 30,096 | 3,177,041 | Sep 08, 2021, 06:29 PM |
| Bonita David P | Director | Sep 03, 2021 | Sale | $34.00 | 7,197 | 244,698 | 3,177,902 | Sep 08, 2021, 06:29 PM |
| ORBIMED ADVISORS LLC | Director | Sep 07, 2021 | Sale | $33.93 | 887 | 30,096 | 3,177,041 | Sep 08, 2021, 06:18 PM |
| ORBIMED ADVISORS LLC | Director | Sep 03, 2021 | Sale | $34.00 | 7,197 | 244,698 | 3,177,902 | Sep 08, 2021, 06:18 PM |
| ORBIMED ADVISORS LLC | Director | Sep 01, 2021 | Sale | $33.98 | 12,968 | 440,653 | 3,200,828 | Sep 02, 2021, 08:27 PM |
| ORBIMED ADVISORS LLC | Director | Aug 31, 2021 | Sale | $33.94 | 8,472 | 287,540 | 3,213,414 | Sep 02, 2021, 08:27 PM |
| ORBIMED ADVISORS LLC | Director | Sep 02, 2021 | Sale | $34.24 | 16,424 | 562,358 | 3,184,887 | Sep 02, 2021, 08:27 PM |
| Bonita David P | Director | Sep 02, 2021 | Sale | $34.24 | 16,424 | 562,358 | 3,184,887 | Sep 02, 2021, 08:20 PM |
| Bonita David P | Director | Sep 01, 2021 | Sale | $33.98 | 12,968 | 440,653 | 3,200,828 | Sep 02, 2021, 08:20 PM |
| Bonita David P | Director | Aug 31, 2021 | Sale | $33.94 | 8,472 | 287,540 | 3,213,414 | Sep 02, 2021, 08:20 PM |
| ORBIMED ADVISORS LLC | Director | Aug 26, 2021 | Sale | $34.52 | 4,283 | 147,849 | 3,235,021 | Aug 30, 2021, 06:37 PM |
| ORBIMED ADVISORS LLC | Director | Aug 30, 2021 | Sale | $33.92 | 6,697 | 227,162 | 3,221,637 | Aug 30, 2021, 06:37 PM |
| ORBIMED ADVISORS LLC | Director | Aug 27, 2021 | Sale | $33.94 | 7,093 | 240,736 | 3,228,137 | Aug 30, 2021, 06:37 PM |
| Bonita David P | Director | Aug 30, 2021 | Sale | $33.92 | 6,697 | 227,162 | 3,221,637 | Aug 30, 2021, 06:33 PM |
| Bonita David P | Director | Aug 27, 2021 | Sale | $33.94 | 7,093 | 240,736 | 3,228,137 | Aug 30, 2021, 06:33 PM |
| Bonita David P | Director | Aug 26, 2021 | Sale | $34.52 | 4,283 | 147,849 | 3,235,021 | Aug 30, 2021, 06:33 PM |
| ORBIMED ADVISORS LLC | Director | Aug 23, 2021 | Sale | $34.06 | 7,094 | 241,622 | 3,249,972 | Aug 25, 2021, 08:43 PM |
| ORBIMED ADVISORS LLC | Director | Aug 25, 2021 | Sale | $34.34 | 7,082 | 243,196 | 3,239,178 | Aug 25, 2021, 08:43 PM |
| ORBIMED ADVISORS LLC | Director | Aug 24, 2021 | Sale | $34.07 | 4,039 | 137,609 | 3,246,052 | Aug 25, 2021, 08:43 PM |
| Bonita David P | Director | Aug 25, 2021 | Sale | $34.34 | 7,082 | 243,196 | 3,239,178 | Aug 25, 2021, 08:36 PM |
| Bonita David P | Director | Aug 24, 2021 | Sale | $34.07 | 4,039 | 137,609 | 3,246,052 | Aug 25, 2021, 08:36 PM |
| Bonita David P | Director | Aug 23, 2021 | Sale | $34.06 | 7,094 | 241,622 | 3,249,972 | Aug 25, 2021, 08:36 PM |
| Bonita David P | Director | Aug 18, 2021 | Sale | $33.99 | 2,930 | 99,591 | 3,256,857 | Aug 25, 2021, 08:25 PM |
| Bonita David P | Director | Aug 17, 2021 | Sale | $34.12 | 17,398 | 593,620 | 3,259,439 | Aug 25, 2021, 08:25 PM |
| Zinda Michael | EVP, Chief Science Officer | Aug 16, 2021 | Sale | $33.99 | 15,000 | 509,886 | 21,233 | Aug 20, 2021, 04:24 PM |
| ORBIMED ADVISORS LLC | Director | Aug 18, 2021 | Sale | $33.99 | 2,930 | 99,591 | 3,256,857 | Aug 19, 2021, 08:55 PM |
| ORBIMED ADVISORS LLC | Director | Aug 17, 2021 | Sale | $34.12 | 17,398 | 593,620 | 3,259,439 | Aug 19, 2021, 08:55 PM |
| Bonita David P | Director | Aug 18, 2021 | Sale | $33.99 | 2,930 | 99,591 | 3,256,857 | Aug 19, 2021, 08:49 PM |
| Bonita David P | Director | Aug 17, 2021 | Sale | $34.12 | 17,398 | 593,620 | 3,259,439 | Aug 19, 2021, 08:49 PM |
| Foley Todd | Director | Jul 12, 2021 | Sale | $33.59 | 25,559 | 858,434 | 2,242,949 | Jul 13, 2021, 04:22 PM |
| Foley Todd | Director | Jul 09, 2021 | Sale | $33.06 | 1,792 | 59,244 | 2,268,195 | Jul 13, 2021, 04:22 PM |
| GADICKE ANSBERT | 10% Owner | Jul 12, 2021 | Sale | $33.59 | 58,012 | 1,948,413 | 3,883,196 | Jul 13, 2021, 04:21 PM |
| GADICKE ANSBERT | 10% Owner | Jul 09, 2021 | Sale | $33.06 | 4,067 | 134,455 | 3,940,497 | Jul 13, 2021, 04:21 PM |
| Segal Lloyd Mitchell | President and CEO | Jun 28, 2021 | Sale | $35.61 | 1,542 | 54,911 | 94,466 | Jun 30, 2021, 05:54 PM |
| Foley Todd | Director | Jun 29, 2021 | Sale | $33.29 | 1,190 | 39,615 | 2,269,987 | Jun 30, 2021, 05:26 PM |
| Foley Todd | Director | Jun 28, 2021 | Sale | $34.18 | 7,270 | 248,521 | 2,272,367 | Jun 30, 2021, 05:26 PM |
| GADICKE ANSBERT | 10% Owner | Jun 28, 2021 | Sale | $34.18 | 16,500 | 564,042 | 3,949,964 | Jun 30, 2021, 05:25 PM |
| GADICKE ANSBERT | 10% Owner | Jun 29, 2021 | Sale | $33.29 | 2,700 | 89,883 | 3,944,564 | Jun 30, 2021, 05:25 PM |
| Foley Todd | Director | Jun 23, 2021 | Sale | $32.98 | 622 | 20,514 | 2,291,087 | Jun 23, 2021, 05:38 PM |
| Foley Todd | Director | Jun 22, 2021 | Sale | $33.44 | 1,675 | 56,016 | 2,291,898 | Jun 23, 2021, 05:38 PM |
| Foley Todd | Director | Jun 21, 2021 | Sale | $34.50 | 16,562 | 571,421 | 2,307,390 | Jun 23, 2021, 05:38 PM |
| GADICKE ANSBERT | 10% Owner | Jun 23, 2021 | Sale | $32.98 | 1,410 | 46,502 | 3,992,452 | Jun 23, 2021, 05:38 PM |
| GADICKE ANSBERT | 10% Owner | Jun 22, 2021 | Sale | $33.44 | 3,800 | 127,081 | 3,994,291 | Jun 23, 2021, 05:38 PM |
| GADICKE ANSBERT | 10% Owner | Jun 21, 2021 | Sale | $34.50 | 37,588 | 1,296,858 | 4,029,450 | Jun 23, 2021, 05:38 PM |
| GADICKE ANSBERT | 10% Owner | Jun 18, 2021 | Sale | $33.66 | 9,000 | 302,963 | 4,038,449 | Jun 21, 2021, 04:06 PM |
| GADICKE ANSBERT | 10% Owner | Jun 17, 2021 | Sale | $33.80 | 32,518 | 1,099,039 | 4,045,958 | Jun 21, 2021, 04:06 PM |
| GADICKE ANSBERT | 10% Owner | Jun 16, 2021 | Sale | $33.33 | 4,227 | 140,886 | 4,076,768 | Jun 16, 2021, 05:09 PM |
| GADICKE ANSBERT | 10% Owner | Jun 14, 2021 | Sale | $33.09 | 2,000 | 66,180 | 4,080,995 | Jun 16, 2021, 05:09 PM |
| Segal Lloyd Mitchell | President and CEO | Jun 09, 2021 | Sale | $35.00 | 1,576 | 55,160 | 96,008 | Jun 10, 2021, 06:35 PM |
| Foley Todd | Director | Jun 08, 2021 | Sale | $33.20 | 11,544 | 383,254 | 2,354,065 | Jun 10, 2021, 04:05 PM |
| Foley Todd | Director | Jun 09, 2021 | Sale | $34.68 | 15,523 | 538,275 | 2,341,721 | Jun 10, 2021, 04:05 PM |
| GADICKE ANSBERT | 10% Owner | Jun 09, 2021 | Sale | $34.68 | 35,230 | 1,221,633 | 4,107,363 | Jun 10, 2021, 04:04 PM |
| GADICKE ANSBERT | 10% Owner | Jun 08, 2021 | Sale | $33.20 | 26,200 | 869,825 | 4,135,380 | Jun 10, 2021, 04:04 PM |
| Foley Todd | Director | Jun 07, 2021 | Sale | $32.68 | 10,186 | 332,850 | 2,367,178 | Jun 07, 2021, 06:40 PM |
| Foley Todd | Director | Jun 04, 2021 | Sale | $30.98 | 5,612 | 173,842 | 2,370,304 | Jun 07, 2021, 06:40 PM |
| Foley Todd | Director | Jun 03, 2021 | Sale | $31.92 | 9,824 | 313,582 | 2,373,848 | Jun 07, 2021, 06:40 PM |
| Foley Todd | Director | Jun 02, 2021 | Sale | $31.86 | 2,738 | 87,227 | 2,383,802 | Jun 02, 2021, 05:40 PM |
| Foley Todd | Director | Jun 01, 2021 | Sale | $32.50 | 6,671 | 216,808 | 2,386,410 | Jun 02, 2021, 05:40 PM |
| Foley Todd | Director | May 28, 2021 | Sale | $32.67 | 7,377 | 241,007 | 2,393,081 | Jun 02, 2021, 05:40 PM |
| GADICKE ANSBERT | 10% Owner | Jun 01, 2021 | Sale | $32.50 | 15,141 | 492,083 | 4,208,789 | Jun 02, 2021, 05:39 PM |
| GADICKE ANSBERT | 10% Owner | May 28, 2021 | Sale | $32.67 | 16,742 | 546,961 | 4,223,930 | Jun 02, 2021, 05:39 PM |
| GADICKE ANSBERT | 10% Owner | Jun 02, 2021 | Sale | $31.86 | 6,215 | 197,999 | 4,202,871 | Jun 02, 2021, 05:39 PM |
| GADICKE ANSBERT | 10% Owner | May 25, 2021 | Sale | $32.88 | 6,572 | 216,094 | 4,272,759 | May 27, 2021, 07:41 PM |
| GADICKE ANSBERT | 10% Owner | May 27, 2021 | Sale | $32.97 | 7,951 | 262,141 | 4,244,296 | May 27, 2021, 07:41 PM |
| GADICKE ANSBERT | 10% Owner | May 26, 2021 | Sale | $32.76 | 24,036 | 787,399 | 4,250,327 | May 27, 2021, 07:41 PM |
| Foley Todd | Director | May 24, 2021 | Sale | $34.12 | 9,782 | 333,795 | 2,425,666 | May 24, 2021, 08:13 PM |
| Foley Todd | Director | May 21, 2021 | Sale | $34.80 | 133,359 | 4,640,893 | 2,427,229 | May 24, 2021, 08:13 PM |
| GADICKE ANSBERT | 10% Owner | May 20, 2021 | Sale | $34.69 | 9,957 | 345,428 | 4,604,700 | May 20, 2021, 07:56 PM |
| GADICKE ANSBERT | 10% Owner | May 19, 2021 | Sale | $34.48 | 13,543 | 466,965 | 4,618,457 | May 20, 2021, 07:56 PM |
| GADICKE ANSBERT | 10% Owner | May 18, 2021 | Sale | $34.16 | 23,404 | 799,571 | 4,658,065 | May 20, 2021, 07:56 PM |
| Segal Lloyd Mitchell | President and CEO | May 19, 2021 | Sale | $35.06 | 3,800 | 133,228 | 137,354 | May 20, 2021, 06:19 PM |
| Segal Lloyd Mitchell | President and CEO | May 18, 2021 | Sale | $35.00 | 1,800 | 63,000 | 141,154 | May 20, 2021, 06:19 PM |
| Segal Lloyd Mitchell | President and CEO | Apr 15, 2021 | Sale | $35.01 | 5,512 | 192,975 | 142,954 | Apr 19, 2021, 05:44 PM |
| Foley Todd | Director | Mar 12, 2021 | Sale | $28.18 | 376,412 | 10,607,290 | 2,627,360 | Mar 15, 2021, 05:11 PM |
| GADICKE ANSBERT | 10% Owner | Mar 12, 2021 | Sale | $28.18 | 695,000 | 19,585,100 | 4,697,109 | Mar 15, 2021, 05:10 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 28, 2020 | Option Exercise | $2.06 | 48 | 99 | 85,277 | Dec 30, 2020, 05:10 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 28, 2020 | Sale | $34.25 | 15,048 | 515,359 | 70,551 | Dec 30, 2020, 05:10 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 29, 2020 | Sale | $33.67 | 19,696 | 663,097 | 55,690 | Dec 30, 2020, 05:10 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 22, 2020 | Option Exercise | $1.90 | 41,312 | 78,510 | 126,541 | Dec 28, 2020, 04:40 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 24, 2020 | Option Exercise | $2.06 | 432 | 891 | 85,661 | Dec 28, 2020, 04:40 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 23, 2020 | Option Exercise | $2.22 | 16,235 | 36,081 | 101,464 | Dec 28, 2020, 04:40 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 24, 2020 | Sale | $33.14 | 432 | 14,316 | 85,229 | Dec 28, 2020, 04:40 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 23, 2020 | Sale | $33.66 | 16,235 | 546,417 | 88,908 | Dec 28, 2020, 04:40 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 22, 2020 | Sale | $33.38 | 41,312 | 1,379,200 | 124,929 | Dec 28, 2020, 04:40 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 21, 2020 | Option Exercise | $2.42 | 40,000 | 97,000 | 125,229 | Dec 22, 2020, 04:37 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 21, 2020 | Sale | $33.08 | 40,000 | 1,323,200 | 85,229 | Dec 22, 2020, 04:37 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 16, 2020 | Option Exercise | $1.64 | 8,956 | 14,661 | 94,185 | Dec 18, 2020, 08:29 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 18, 2020 | Option Exercise | $2.06 | 8,321 | 17,158 | 93,550 | Dec 18, 2020, 08:29 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 18, 2020 | Sale | $34.60 | 8,321 | 287,925 | 85,429 | Dec 18, 2020, 08:29 PM |
| Zinda Michael | EVP, Chief Science Officer | Dec 16, 2020 | Sale | $35.26 | 8,956 | 315,767 | 86,163 | Dec 18, 2020, 08:29 PM |
| Versant Vantage I, L.P. | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 250,000 | 5,000,000 | 3,419,451 | Jun 25, 2020, 07:40 PM |
| Jerel Davis | Director | Jun 23, 2020 | Buy | $20.00 | 250,000 | 5,000,000 | 3,419,451 | Jun 25, 2020, 07:09 PM |
| Versant Ventures V, LLC | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 250,000 | 5,000,000 | 3,419,451 | Jun 25, 2020, 06:46 PM |
| Segal Lloyd Mitchell | President and CEO | Jun 23, 2020 | Buy | $20.00 | 5,000 | 100,000 | 5,000 | Jun 25, 2020, 06:00 PM |
| Forte Steve | EVP, Chief Financial Officer | Jun 23, 2020 | Buy | $20.00 | 5,000 | 100,000 | 5,000 | Jun 25, 2020, 05:59 PM |
| SCHAFER CAROL | Director | Jun 23, 2020 | Buy | $20.00 | 8,000 | 160,000 | 8,000 | Jun 25, 2020, 05:58 PM |
| Morrison Briggs | Director | Jun 23, 2020 | Buy | $20.00 | 4,800 | 96,000 | 4,800 | Jun 25, 2020, 05:57 PM |
| RHOADS ANN D | Director | Jun 23, 2020 | Buy | $20.00 | 4,000 | 80,000 | 4,000 | Jun 25, 2020, 05:55 PM |
| Bonita David P | Director | Jun 23, 2020 | Buy | $20.00 | 774,200 | 15,484,000 | 3,276,325 | Jun 25, 2020, 05:54 PM |
| ORBIMED ADVISORS LLC | Director | Jun 23, 2020 | Buy | $20.00 | 99,200 | 1,984,000 | 99,200 | Jun 25, 2020, 05:53 PM |
| ORBIMED ADVISORS LLC | Director | Jun 23, 2020 | Buy | $20.00 | 675,000 | 13,500,000 | 3,276,325 | Jun 25, 2020, 05:53 PM |
| GADICKE ANSBERT | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 500,000 | 10,000,000 | 5,392,109 | Jun 25, 2020, 04:33 PM |
| Foley Todd | Director | Jun 23, 2020 | Buy | $20.00 | 250,000 | 5,000,000 | 3,003,772 | Jun 25, 2020, 04:32 PM |
| MPM BioVentures 2014, L.P. | 10% Owner | Jun 23, 2020 | Buy | $20.00 | 250,000 | 5,000,000 | 3,003,772 | Jun 25, 2020, 04:31 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | 04/01/2024 | 11,533 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | 03/28/2024 | 12,243 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | 03/28/2024 | 3,811 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | 04/01/2024 | 3,637 |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | 04/01/2024 | 1,911 |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | 03/28/2024 | 2,088 |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | 04/01/2024 | 1,398 |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | 03/28/2024 | 2,320 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | 03/27/2024 | 3,811 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | 03/26/2024 | 3,795 |
| Forte Steve | EVP, CHIEF FINANCIAL OFFICER | 03/25/2024 | 3,952 |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | 03/26/2024 | 2,075 |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | 03/25/2024 | 2,151 |
| Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | 03/27/2024 | 2,079 |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | 03/26/2024 | 2,300 |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | 03/25/2024 | 2,390 |
| Koehler Maria | EVP, CHIEF MEDICAL OFFICER | 03/27/2024 | 2,310 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | 03/27/2024 | 12,270 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | 03/26/2024 | 12,296 |
| Segal Lloyd Mitchell | PRESIDENT AND CEO | 03/25/2024 | 12,693 |
| Koehler Maria | EVP, Chief Medical Officer | 12/11/2023 | 98,755 |
| BVF PARTNERS L P/IL | 10% Owner | 11/16/2023 | 1,592,202 |
| BVF PARTNERS L P/IL | 10% Owner | 11/15/2023 | 4,657,687 |
| BVF PARTNERS L P/IL | 10% Owner | 11/02/2023 | 2,821,352 |
| Zinda Michael | EVP, Chief Scientific Officer | 06/08/2023 | 34,485 |
| Zinda Michael | EVP, Chief Scientific Officer | 06/07/2023 | 77,040 |
| Zinda Michael | EVP, Chief Scientific Officer | 06/06/2023 | 14,448 |
| Koehler Maria | EVP, Chief Medical Officer | 12/20/2022 | 100,040 |
| Jerel Davis | Director | 12/09/2022 | 4,000,000 |
| BVF PARTNERS L P/IL | 10% Owner | 06/13/2022 | 1,898,819 |
| Versant Vantage I, L.P. | 10% Owner | 06/03/2022 | 9,188,775 |
| Versant Ventures V, LLC | 10% Owner | 06/03/2022 | 9,188,775 |
| Jerel Davis | Director | 06/03/2022 | 9,188,775 |
| BVF PARTNERS L P/IL | 10% Owner | 06/02/2022 | 13,855,852 |
| BVF PARTNERS L P/IL | 10% Owner | 06/06/2022 | 90,752 |
| BVF PARTNERS L P/IL | 10% Owner | 06/03/2022 | 7,912,725 |
| BVF PARTNERS L P/IL | 10% Owner | 05/18/2022 | 3,570,000 |
| Zinda Michael | EVP, Chief Science Officer | 03/15/2022 | 6,023 |
| BVF PARTNERS L P/IL | 10% Owner | 01/19/2022 | 14,071,250 |
| Koehler Maria | EVP, Chief Medical Officer | 12/10/2021 | 100,048 |
| Zinda Michael | EVP, Chief Science Officer | 11/23/2021 | 91,948 |
| Civik Thomas | Director | 11/16/2021 | 210,600 |
| Zinda Michael | EVP, Chief Science Officer | 11/15/2021 | 546,613 |
| Bonita David P | Director | 09/07/2021 | 30,096 |
| Bonita David P | Director | 09/03/2021 | 244,698 |
| ORBIMED ADVISORS LLC | Director | 09/07/2021 | 30,096 |
| ORBIMED ADVISORS LLC | Director | 09/03/2021 | 244,698 |
| ORBIMED ADVISORS LLC | Director | 09/01/2021 | 440,653 |
| ORBIMED ADVISORS LLC | Director | 08/31/2021 | 287,540 |
| ORBIMED ADVISORS LLC | Director | 09/02/2021 | 562,358 |
| Bonita David P | Director | 09/02/2021 | 562,358 |
| Bonita David P | Director | 09/01/2021 | 440,653 |
| Bonita David P | Director | 08/31/2021 | 287,540 |
| ORBIMED ADVISORS LLC | Director | 08/26/2021 | 147,849 |
| ORBIMED ADVISORS LLC | Director | 08/30/2021 | 227,162 |
| ORBIMED ADVISORS LLC | Director | 08/27/2021 | 240,736 |
| Bonita David P | Director | 08/30/2021 | 227,162 |
| Bonita David P | Director | 08/27/2021 | 240,736 |
| Bonita David P | Director | 08/26/2021 | 147,849 |
| ORBIMED ADVISORS LLC | Director | 08/23/2021 | 241,622 |
| ORBIMED ADVISORS LLC | Director | 08/25/2021 | 243,196 |
| ORBIMED ADVISORS LLC | Director | 08/24/2021 | 137,609 |
| Bonita David P | Director | 08/25/2021 | 243,196 |
| Bonita David P | Director | 08/24/2021 | 137,609 |
| Bonita David P | Director | 08/23/2021 | 241,622 |
| Bonita David P | Director | 08/18/2021 | 99,591 |
| Bonita David P | Director | 08/17/2021 | 593,620 |
| Zinda Michael | EVP, Chief Science Officer | 08/16/2021 | 509,886 |
| ORBIMED ADVISORS LLC | Director | 08/18/2021 | 99,591 |
| ORBIMED ADVISORS LLC | Director | 08/17/2021 | 593,620 |
| Bonita David P | Director | 08/18/2021 | 99,591 |
| Bonita David P | Director | 08/17/2021 | 593,620 |
| Foley Todd | Director | 07/12/2021 | 858,434 |
| Foley Todd | Director | 07/09/2021 | 59,244 |
| GADICKE ANSBERT | 10% Owner | 07/12/2021 | 1,948,413 |
| GADICKE ANSBERT | 10% Owner | 07/09/2021 | 134,455 |
| Segal Lloyd Mitchell | President and CEO | 06/28/2021 | 54,911 |
| Foley Todd | Director | 06/29/2021 | 39,615 |
| Foley Todd | Director | 06/28/2021 | 248,521 |
| GADICKE ANSBERT | 10% Owner | 06/28/2021 | 564,042 |
| GADICKE ANSBERT | 10% Owner | 06/29/2021 | 89,883 |
| Foley Todd | Director | 06/23/2021 | 20,514 |
| Foley Todd | Director | 06/22/2021 | 56,016 |
| Foley Todd | Director | 06/21/2021 | 571,421 |
| GADICKE ANSBERT | 10% Owner | 06/23/2021 | 46,502 |
| GADICKE ANSBERT | 10% Owner | 06/22/2021 | 127,081 |
| GADICKE ANSBERT | 10% Owner | 06/21/2021 | 1,296,858 |
| GADICKE ANSBERT | 10% Owner | 06/18/2021 | 302,963 |
| GADICKE ANSBERT | 10% Owner | 06/17/2021 | 1,099,039 |
| GADICKE ANSBERT | 10% Owner | 06/16/2021 | 140,886 |
| GADICKE ANSBERT | 10% Owner | 06/14/2021 | 66,180 |
| Segal Lloyd Mitchell | President and CEO | 06/09/2021 | 55,160 |
| Foley Todd | Director | 06/08/2021 | 383,254 |
| Foley Todd | Director | 06/09/2021 | 538,275 |
| GADICKE ANSBERT | 10% Owner | 06/09/2021 | 1,221,633 |
| GADICKE ANSBERT | 10% Owner | 06/08/2021 | 869,825 |
| Foley Todd | Director | 06/07/2021 | 332,850 |
| Foley Todd | Director | 06/04/2021 | 173,842 |
| Foley Todd | Director | 06/03/2021 | 313,582 |
| Foley Todd | Director | 06/02/2021 | 87,227 |
| Foley Todd | Director | 06/01/2021 | 216,808 |
| Foley Todd | Director | 05/28/2021 | 241,007 |
| GADICKE ANSBERT | 10% Owner | 06/01/2021 | 492,083 |
| GADICKE ANSBERT | 10% Owner | 05/28/2021 | 546,961 |
| GADICKE ANSBERT | 10% Owner | 06/02/2021 | 197,999 |
| GADICKE ANSBERT | 10% Owner | 05/25/2021 | 216,094 |
| GADICKE ANSBERT | 10% Owner | 05/27/2021 | 262,141 |
| GADICKE ANSBERT | 10% Owner | 05/26/2021 | 787,399 |
| Foley Todd | Director | 05/24/2021 | 333,795 |
| Foley Todd | Director | 05/21/2021 | 4,640,893 |
| GADICKE ANSBERT | 10% Owner | 05/20/2021 | 345,428 |
| GADICKE ANSBERT | 10% Owner | 05/19/2021 | 466,965 |
| GADICKE ANSBERT | 10% Owner | 05/18/2021 | 799,571 |
| Segal Lloyd Mitchell | President and CEO | 05/19/2021 | 133,228 |
| Segal Lloyd Mitchell | President and CEO | 05/18/2021 | 63,000 |
| Segal Lloyd Mitchell | President and CEO | 04/15/2021 | 192,975 |
| Foley Todd | Director | 03/12/2021 | 10,607,290 |
| GADICKE ANSBERT | 10% Owner | 03/12/2021 | 19,585,100 |
| Zinda Michael | EVP, Chief Science Officer | 12/28/2020 | 99 |
| Zinda Michael | EVP, Chief Science Officer | 12/28/2020 | 515,359 |
| Zinda Michael | EVP, Chief Science Officer | 12/29/2020 | 663,097 |
| Zinda Michael | EVP, Chief Science Officer | 12/22/2020 | 78,510 |
| Zinda Michael | EVP, Chief Science Officer | 12/24/2020 | 891 |
| Zinda Michael | EVP, Chief Science Officer | 12/23/2020 | 36,081 |
| Zinda Michael | EVP, Chief Science Officer | 12/24/2020 | 14,316 |
| Zinda Michael | EVP, Chief Science Officer | 12/23/2020 | 546,417 |
| Zinda Michael | EVP, Chief Science Officer | 12/22/2020 | 1,379,200 |
| Zinda Michael | EVP, Chief Science Officer | 12/21/2020 | 97,000 |
| Zinda Michael | EVP, Chief Science Officer | 12/21/2020 | 1,323,200 |
| Zinda Michael | EVP, Chief Science Officer | 12/16/2020 | 14,661 |
| Zinda Michael | EVP, Chief Science Officer | 12/18/2020 | 17,158 |
| Zinda Michael | EVP, Chief Science Officer | 12/18/2020 | 287,925 |
| Zinda Michael | EVP, Chief Science Officer | 12/16/2020 | 315,767 |
| Versant Vantage I, L.P. | 10% Owner | 06/23/2020 | 5,000,000 |
| Jerel Davis | Director | 06/23/2020 | 5,000,000 |
| Versant Ventures V, LLC | 10% Owner | 06/23/2020 | 5,000,000 |
| Segal Lloyd Mitchell | President and CEO | 06/23/2020 | 100,000 |
| Forte Steve | EVP, Chief Financial Officer | 06/23/2020 | 100,000 |
| SCHAFER CAROL | Director | 06/23/2020 | 160,000 |
| Morrison Briggs | Director | 06/23/2020 | 96,000 |
| RHOADS ANN D | Director | 06/23/2020 | 80,000 |
| Bonita David P | Director | 06/23/2020 | 15,484,000 |
| ORBIMED ADVISORS LLC | Director | 06/23/2020 | 1,984,000 |
| ORBIMED ADVISORS LLC | Director | 06/23/2020 | 13,500,000 |
| GADICKE ANSBERT | 10% Owner | 06/23/2020 | 10,000,000 |
| Foley Todd | Director | 06/23/2020 | 5,000,000 |
| MPM BioVentures 2014, L.P. | 10% Owner | 06/23/2020 | 5,000,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN REPARE THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 3,322,488 | 0.48% | No change | Other |
| ARK INVESTMENT MANAGEMENT LLC | 2,703,783 | 0.09% | -4.17% | Growth |
| RENAISSANCE TECHNOLOGIES LLC | 355,826 | 0.00402% | 132.72% | Other |
| D. E. SHAW & CO., INC. | 77,179 | 0.00049% | New | Other |
| BLACKROCK INC. | 62,701 | 0.00001% | -81.11% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 26,544 | 0.00002% | No change | Other |
| BLACKSTONE INC. | 25,957 | 0.00085% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR REPARE THERAPEUTICS INC
STOCK BUYBACKS FOR REPARE THERAPEUTICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.09%
1Q
06/30/2023
0.12%
2Q
03/31/2023
0.24%
3Q
12/31/2022
19.69%
4Q
09/30/2022
-4.61%
5Q
06/30/2022
0.57%
6Q
03/31/2022
0.66%
7Q
12/31/2021
4.84%
8Q
09/30/2021
13.51%
9Q
06/30/2021
13.78%
10Q
03/31/2021
14.15%
11Q
09/30/2020
14.64%
13Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR REPARE THERAPEUTICS INC
LOADING...